Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04870112
Title A Study to Evaluate Subcutaneous Durvalumab in Patients With Non-Small Cell Lung Cancer and Small Cell Lung Cancer (SCope-D1)
Acronym SCope-D1
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NZL | ESP

Facility Status City State Zip Country Details
Research Site Houston Texas 77090 United States Details
Research Site Fairfax Virginia 22031 United States Details
Research Site Christchurch 8011 New Zealand Details
Research Site Badalona 08916 Spain Details
Research Site Majadahonda 28222 Spain Details
Research Site Taichung 40705 Taiwan Details
Research Site Taipei City 11217 Taiwan Details
Research Site Taipei City 114 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field